AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 APR 17 - (NewsRx.com & NewsRx.net) -- NovaRx Corp. is collaborating with the Hoag Cancer Center in Newport Beach, Calif., to conduct a phase II clinical trial using an experimental cancer vaccine in patients with lung cancer.
Dr. Robert Dillman, medical director of Hoag Cancer Center, is the principal investigator. Dr. Habib Fakhrai, president and CEO of NovaRx, and developer of the award-winning technology being tested in the clinical trial, is the sponsor.
The experimental lung cancer vaccine that will be evaluated in the trial ...
Source: HighBeam Research, Hoag Cancer Center to launch phase II clinical trial in lung cancer...